PYRAMID-ANALYTICS
31.3.2022 16:37:11 CEST | Business Wire | Press release
Experts from Delaware and Pyramid Analytics will explore why and how Decision Intelligence – what’s next in analytics and business intelligence (ABI) – should be introduced into enterprise platforms at the UKISUG Analytics Symposium , an annual event for the independent UK & Ireland SAP User Group being held on 5 April, 2022 at The Vox Conference Centre, Birmingham. The conference offers the opportunity for networking and collaboration among peers specialising in SAP Analytics Cloud, data preparation, platform & database and digital transformation.
UKISUG Analytics Symposium is free to attend. Register here .
Key Points:
- Delaware’s Analytics Lead and Pyramid’s Director of Product Management will discuss Decision Intelligence and how to introduce it into an SAP business and technology ecosystem.
- Delaware implements the Pyramid Decision Intelligence Platform across the UK & Ireland to help organisations leverage the full value of data by providing AI-powered analytics to all decision-makers.
- Both companies have partnerships with SAP and expertise in the SAP technology ecosystem .
- Pyramid Analytics is an official member of the SAP® PartnerEdge® open ecosystem. Pyramid Platform is certified by SAP Certified for SAP BW/4HANA, SAP HANA, and SAP NetWeaver.
Attendees, Mark Your Diaries
Chris Houlder, Analytics Lead at Delaware, and Ian MacDonald, Director of Product Management with Pyramid, will discuss how enterprises running on SAP can best understand their data and how to react to fast-changing conditions, and address the challenges of adopting a holistic platform that works directly on both SAP BW and SAP HANA. The session will also include a demo of the Pyramid Analytics Decision Intelligence platform and how to get more value from these SAP investments. The session begins at 10 a.m. GMT.
Partnership Brings Decision Intelligence to Enterprises Across the UKI
Pyramid Analytics and global IT services company Delaware have a partnership agreement through which the companies jointly sell and implement the Pyramid Platform for decision intelligence and provide consulting services. The partnership puts the Pyramid Platform for decision intelligence into the hands of more than 3,000 Delaware consultants. The Pyramid Platform uniquely combines Data Preparation, Business Analytics, and Data Science in a single Analytics and Business Intelligence (ABI) environment. Leading technology analysts BARC, Dresner Advisory Services, and Gartner rank Pyramid first in critical ABI capabilities .
Pyramid and Delaware have strong partnerships with SAP, the world’s largest provider of Enterprise Application Software. Delaware and Pyramid Analytics jointly deliver solutions enabling customers to integrate sophisticated SAP data sets and non-SAP sources, from a wide range of on-premises and cloud-based data sources, without moving or ingesting the data, through a single decision intelligence platform.
Many of Delaware’s clients have complex landscapes and face challenges pulling together accurate and coherent reporting. Pyramid enables all users, from data scientists to non-technical business users, to maximise their investments in SAP providing for the fastest, direct querying and analytics on BW, BEx, HANA, CDS and IQ, while maintaining the investment in business logic and security designed into SAP — all within a complete point and click, no-code, governed self-service analytics environment.
Quotes
Ian Macdonald, Director of Product Management, Pyramid Analytics : “Business success in today’s dynamic markets requires organizations to react to trends and opportunities in real time with accuracy, speed and scale. Data drives better decisions. However, due to legacy tool limitations, integration issues and data management challenges, many SAP customers struggle to expose all the necessary data to deliver modern self-service analytic capabilities. Pyramid Decision Intelligence Platform allows business users to get more value out of their existing SAP BW and SAP HANA investments, delivering best-in-class functionality and performance that preserves the security and governance inherent in the SAP platform.”
Complete, Unified Decision Intelligence
Pyramid’s Decision Intelligence Platform unifies Data Preparation, Business Analytics, and Data Science on a single, integrated platform. This eliminates the need to use multiple disparate tools and the associated license cost and management complexity. Lower Total Cost of Ownership (TCO), rapid rollout, quicker and direct access to all available data, and industry-leading user adoption means faster time to value. Pyramid’s Decision Intelligence Platform can be deployed on-premises, into a private or public cloud, embedded into other apps or delivered through Managed Services Providers (MSP).
About Delaware
Delaware is a fast-growing, global company that delivers advanced solutions and services to organisations striving for a sustainable, competitive advantage. Delaware guides its customers through their business transformation, applying the ecosystems of its main business partners, SAP and Microsoft. Delaware continues to service its customers afterwards, assuring continuity and continuous improvement. Delaware has over 3000 professionals in 24 offices around the world. For more information, please visit www.delaware.co.uk .
About Pyramid Analytics
Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Schedule a demo .
Pyramid Analytics is incorporated in Amsterdam and has regional headquarters in global innovation and business centers, including London, New York City, and Tel-Aviv. Our team lives worldwide because geography should not be a barrier to talent and opportunity. Investors include Jerusalem Venture Partners (JVP), Sequoia Capital and Viola Growth. Learn more at Pyramid Analytics .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220331005705/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Inspirit Capital to Acquire Kaplan Languages Group20.4.2026 17:15:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, is pleased to announce its plans to acquire KLG Kaplan Languages Group (“KLG”), a leading global language education platform, from Kaplan. All conditions for the sale have been met, and completion is due to take place on 1 May. KLG comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Since 2006, KLG has provided high-quality language education, supporting students in achieving their language goals through academic excellence, cultural immersion, and life-changing experiences. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. This next phase of ownership will also see the development of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. Paul Youens, Investment Director, Inspirit Capital: “KLG has built a st
Cleaner by Design: SaniSure Introduces PETG PharmaTainer™ Ultra-Clean Bottles & Carboys20.4.2026 16:00:00 CEST | Press release
Industry’s most widely adopted PETG material meets industry-leading cleanliness, compliance, and RNase/DNase-free validation—now available across the full bioprocessing workflow. SaniSure® today announced the launch of PETG PharmaTainer™, a new line of bioprocessing bottles and carboys combining widely accepted, medical-grade Eastman Eastar® PETG 6763 resin (DMF#9987) with SaniSure’s proprietary process and advanced automation. This launch expands SaniSure’s established PharmaTainer® platform—extending its proven cleanliness, robustness, and performance attributes to include industry-standard PETG alongside its existing PET and PC offerings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420641769/en/ PETG PharmaTainer™ bottles and carboys—RNase/DNase-free, ultra-clean, ready-to-use containers for bioprocessing applications. Available in volumes from 10 mL stability vials to 10 L carboys — in sterile (gamma-irradiated) an
Leaders of Dubai-Based Unicorns Hail City as Global Innovation Hub Shaping Future Technology and Driving the Digital Economy20.4.2026 15:08:00 CEST | Press release
Leaders of Dubai-based unicorn companies have reaffirmed the emirate’s status as a global hub for digital innovation and technology-led growth. The senior executives highlighted Dubai’s forward-looking regulatory environment, advanced infrastructure, and ability to attract international talent as key factors strengthening its appeal for high-growth digital businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420503062/en/ Leaders of Dubai-based unicorns hail city as global innovation hub shaping future technology and driving the digital economy (Photo: AETOSWire) They noted that Dubai has evolved into a strategic launchpad for ambitious companies, offering an agile business environment that supports innovation and enables expansion into regional and international markets. The business leaders also praised the strong alignment between the public and private sectors within Dubai’s digital ecosystem, supported by Dubai
Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 15:00:00 CEST | Press release
– Highly innovative and original gameplay earns strong reception from players around the globe – Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broade
Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 14:30:00 CEST | Press release
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom